Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Nunes

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA surveyShaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
Frontiers in Oncology|October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers|November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha SurveyChiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Eclinicalmedicine|April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registryJon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Blood|September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA surveyLivio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Hematological Oncology|December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registryPellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
Journal of Hematology & Oncology|August 26, 2022
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLLDarko Antic, Natasa Milic, Thomas Chatzikonstantinou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Haematologica|April 4, 2024
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registryTommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA surveyShaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
Frontiers in Oncology|October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers|November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha SurveyChiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Eclinicalmedicine|April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registryJon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Blood|September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA surveyLivio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Hematological Oncology|December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registryPellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
Journal of Hematology & Oncology|August 26, 2022
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLLDarko Antic, Natasa Milic, Thomas Chatzikonstantinou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Haematologica|April 4, 2024
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registryTommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, et al.
Pageof 10